Literature DB >> 23391224

Comparative analysis of the biological and physical properties of Enterococcus faecalis bacteriophage vB_EfaS_GEC-EfS_3 and Streptococcus mitis bacteriophage vB_SmM_GEC-SmitisM_2.

Sophio Rigvava1, Irina Tchgkonia, Darejan Jgenti, Teona Dvalidze, James Carpino, Marina Goderdzishvili.   

Abstract

Enterococcus faecalis and Streptococcus mitis are common commensal inhabitants of the human gastrointestinal and genitourinary tracts. However, both species can be opportunistic pathogens and cause disease in nosocomial settings. These infections can be difficult to treat because of the frequency of antibiotic resistance among these strains. Bacteriophages are often suggested as an alternative therapeutic agent against these infections. In this study, E. faecalis and S. mitis strains were isolated from female patients with urinary tract infections. Bacteriophages active against these strains were isolated from sewage water from the Mtkvari River. Two phages, designated vB_EfaS_GEC-EfS_3 (Syphoviridae) and vB_SmM_GEC-SmitisM_2 (Myoviridae), were specific for E. faecalis and S. mitis, respectively. Each phage's growth patterns and adsorption rates were quantified. Sensitivity to ultraviolet light and temperature was determined, as was host range and serology. The S. mitis bacteriophage was found to be more resistant to ultraviolet light and exposure to high temperatures than the E. faecalis bacteriophage, despite having a much greater rate of replication. While each phage was able to infect a broad range of strains of the same species as the host species from which they were isolated, they were unable to infect other host species tested.

Entities:  

Mesh:

Year:  2012        PMID: 23391224     DOI: 10.1139/cjm-2012-0385

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  8 in total

1.  Diverse virulent pneumophages infect Streptococcus mitis.

Authors:  Siham Ouennane; Philippe Leprohon; Sylvain Moineau
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

2.  Structural proteins of Enterococcus faecalis bacteriophage ϕEf11.

Authors:  Roy H Stevens; Hongming Zhang; Chaiwing Hsiao; Scott Kachlany; Eduardo M B Tinoco; Jessica DePew; Derrick E Fouts
Journal:  Bacteriophage       Date:  2016-11-04

Review 3.  Phage therapy against Enterococcus faecalis in dental root canals.

Authors:  Leron Khalifa; Mor Shlezinger; Shaul Beyth; Yael Houri-Haddad; Shunit Coppenhagen-Glazer; Nurit Beyth; Ronen Hazan
Journal:  J Oral Microbiol       Date:  2016-09-16       Impact factor: 5.474

4.  The Novel Enterococcus Phage vB_EfaS_HEf13 Has Broad Lytic Activity Against Clinical Isolates of Enterococcus faecalis.

Authors:  Dongwook Lee; Jintaek Im; Hongjun Na; Sangryeol Ryu; Cheol-Heui Yun; Seung Hyun Han
Journal:  Front Microbiol       Date:  2019-12-17       Impact factor: 5.640

Review 5.  Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.

Authors:  Zahra Chegini; Amin Khoshbayan; Soheil Vesal; Alireza Moradabadi; Ali Hashemi; Aref Shariati
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-04-26       Impact factor: 3.944

6.  Two Novel Lytic Bacteriophages Infecting Enterococcus spp. Are Promising Candidates for Targeted Antibacterial Therapy.

Authors:  Pavel V Tkachev; Ivan M Pchelin; Daniil V Azarov; Andrey N Gorshkov; Olga V Shamova; Alexander V Dmitriev; Artemiy E Goncharov
Journal:  Viruses       Date:  2022-04-16       Impact factor: 5.818

7.  Isolation and characterization of numerous novel phages targeting diverse strains of the ubiquitous and opportunistic pathogen Achromobacter xylosoxidans.

Authors:  Johannes Wittmann; Brigitte Dreiseikelmann; Christine Rohde; Manfred Rohde; Johannes Sikorski
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

8.  Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent.

Authors:  Ia Kusradze; Natia Karumidze; Sophio Rigvava; Teona Dvalidze; Malkhaz Katsitadze; Irakli Amiranashvili; Marina Goderdzishvili
Journal:  Front Microbiol       Date:  2016-10-04       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.